MoneyWorks4Me

Dr. Reddy's Laboratories informs about press release

19 Oct 2021 Evaluate

Dr. Reddy's Laboratories has informed that it enclosed a Press Release dated October 19, 2021 ‘Dr. Reddy's Laboratories announces approval for Lenalidomide Capsules from the U.S. Food and Drug Administration (USFDA)’.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..